Answer
Carbamazepine, a strong CYP3A inducer, decreased imlunestrant AUC by 42% and maximum concentration (Cmax) by 29%; concomitant use should be avoided, or if unavoidable, the imlunestrant dose should be increased by 200 mg once daily.
Sources for this answer
- Inluriyo 200 mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked